Abstract

The article deals with the aspects of clinical definition of transient ischemic attack (TIA), the analysis of these risk factors for stroke after TIA and their etiopathogenetic relationship. The features of management of patients with high risk of stroke after TIA are discussed. The issues of interdisciplinary and multidisciplinary approach to medical rehabilitation (MR) of patients with TIA are covered. The results of our own studies of the effectiveness of the MR program in 351 patients with TIA with the inclusion of neurocytoprotectors (choline alfoscerate, Cerepro) are presented. Results and conclusion. Pathogenetically justified is the inclusion in MR of patients with TIA of drugs with neurocalibration effect. The high efficiency of choline alfoscerate (Cerepro) in the form of improving cognitive functions, reducing the severity of emotional disorders and reducing the number of cases of recurrent acute cerebrovascular event is shown.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call